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Abstract
Background: Cardiac arrest in patients with pulmonary embolism (PE) is associated with high morbidity and mortality.
Thrombolysis is expected to improve the outcome in these patients. However studies evaluating rescue-thrombolysis in
patients with PE are missing, mainly due to the difficulties of clinical diagnosis of PE. We aimed to determine the success
influencing factors of thrombolysis during resuscitation in patients with PE.
Methodology/Principal Findings: We analyzed retrospectively the outcome of 104 consecutive patients with confirmed
(n=63) or highly suspected (n=41) PE and monitored cardiac arrest. In all patients rtPA was administrated for
thrombolysis during cardiopulmonary resuscitation. In 40 of the 104 patients (38.5%) a return of spontaneous circulation
(ROSC) could be achieved successfully. Patients with ROSC received thrombolysis significantly earlier after CPR onset
compared to patients without ROSC (13.661.2 min versus 24.660.8 min; p,0.001). 19 patients (47.5%) out of the 40
patients with initially successful resuscitation survived to hospital discharge. In patients with hospital discharge
thrombolysis therapy was begun with a significantly shorter delay after cardiac arrest compared to all other patients
(11.061.3 vs. 22.560.9 min; p,0.001).
Conclusion: Rescue-thrombolysis should be considered and started in patients with PE and cardiac arrest, as soon as
possible after cardiac arrest onset.
Citation: Er F, Nia AM, Gassanov N, Caglayan E, Erdmann E, et al. (2009) Impact of Rescue-Thrombolysis during Cardiopulmonary Resuscitation in Patients with
Pulmonary Embolism. PLoS ONE 4(12): e8323. doi:10.1371/journal.pone.0008323
Editor: German Malaga, Universidad Peruana Cayetano Heredia, Peru
Received October 14, 2009; Accepted November 19, 2009; Published December 15, 2009
Copyright:  2009 Er et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding source: Center for
Molecular Medicine Cologne, Cologne, Germany.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Fikret.Er@uk-koeln.de
Introduction
In Europe pulmonary embolism (PE) mortality ranges from3.4
in Norway to 12.8 per 100.000 habitants in Austria [1].
Fulminant PE is associated with cardiac arrest in 10–20% of
cases, which is the major cause of increased mortality rate of 65%
to 95% [2,3]. Cardiac arrest is driven by multiple mechanisms,
most importantly by obstructive shock with severe dysfunction of
the right ventricle [4,5,6]. PE causes up to 15% of hospital deaths
[7,8].
Thrombolysis in PE is recommended in patients with shock and
hypotension [9]. However, it is unclear whether in patients with
cardiac arrest and cardiopulmonary resuscitation (CPR) throm-
bolysis is advisable. While over years guidelines listed CPR as a
contraindication for thrombolysis [10], newer guidelines recom-
mend to consider thrombolysis therapy during CPR in patients
with proven or suspected pulmonary embolism [9]. In clinical
practice thrombolysis therapy is generally applied by the rescue
team in the case of unsuccessful resuscitation as the ‘‘last chance’’
of the patient. Beside the economic concerns of this regime
efficiency of thrombolysis therapy during CPR in patients with
documented or highly suspected PE remains unknown. Throm-
bolysis in unselected patients with out-of-hospital cardiac arrest
was not beneficial [11].
Methods
Patients
We identified patients with in-hospital witnessed cardiac arrest,
who were initially admitted to the intensive or intermediate care
unit of the University Hospital of Cologne with dyspnea and the
clinical suspicion of PE between 2004 and 2008. Patients were
included in the analysis either, when PE was verified by CT-scan,
ventilation/perfusion (V/P) scintigraphy, transesophageal echo-
cardiography or postmortem section. In case of missing objective
detection of PE, patients were included when a high probability of
PE was present, reflected by a Wells score .6 [12], elevated serum
D-dimer concentration and additional echocardiographic signs of
right heart failure. All patients received intraveneous recombinant
tissue plasminogen activator (rtPA) during CPR. The time of
cardiac arrest and the onset of rtPA administration were noticed in
patient’s charts and/or additionally in a CPR-protocol of the
University Hospital of Cologne. Return of spontaneous circulation
(ROSC) was defined as sufficient mean arterial blood pressure
($65 mmHg) without mechanical thorax compressions. The
neurological outcome was assessed by Cerebral Performance
Categories (CPC), where CPC 1 indicates a good cerebral
performance, CPC 2 moderate cerebral disability, CPC 3 severe
neurological disability, CPC 4 coma or vegetative state and CPC 5
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Statistical Analysis
All variables were tested for normal distribution with the
Kolmogorov-Smirnov test. Continuous variables are expressed
as means 6 standard error of the mean. Comparison of 2 means
was performed with the t test for normally distributed variables
and the Mann-Whitney U test for non-Gaussian variables. Chi-
quadrat test was used for nonparametric comparisons. All
statistical tests were 2-tailed, and p,0.05 was considered
statistically significant.
Results
Baseline Characeristics
We identified 104 patients at age of 61.561.4 years with cardiac
arrest and consecutive resuscitation due to verified or highly
suspected PE. The baseline characteristics are summarized in
table 1. In 63 patients PE was objectified by CT-scan (n=45),
transesophageal echocardiography (n=12), V/P scintigraphy
(n=3) or postmortem section (n=3). A mean Wells score of
7.060.34 revealed a high probability of PE in patients without
objective verification of PE. The cardiac rhythm documented at
the onset of cardiac arrest was sinus arrest or electromechanical
dissociation in 61 patients and ventricular or supraventricular
tachycardia or ventricular fibrillation in 43 patients. In all cases
rtPA was administrated for fibrinolysis as a bolus injection in few
minutes at a mean concentration of 80.562.4 mg. The decision
for thrombolysis, dosage and time of onset was made by the rescue
team.
Effect of Thrombolysis during CPR
In 40 (38.5%) of 104 patients thrombolysis and resuscitation
was successful with ROSC. The baseline characteristics were not
different in patients with and without ROSC (Table 1). The time
between cardiac arrest and rtPA administration was significantly
s h o r t e ri np a t i e n t sw i t hR O S C( 1 3 . 6 61.2 min) compared to
patients without ROSC (24.760.8 min; p,0.001; Figure 1A).
The mean CPR duration was longer in patients without ROSC
than with ROSC (67.561.5 vs. 39.561.7 minutes; p,0.001;
Figure 1A).
19/40 patients (47.5%) with ROSC survived to hospital
discharge. Of multiple evaluated parameters (age, gender,
comorbidities, medication, BMI, rtPA dosage) the only predictive
univariate value for successful hospital discharge was the time
between cardiac arrest and initiation of fibrinolysis: patients who
could be discharged received thrombolysis significantly earlier
compared to all other patients (11.061.3 min vs. 22.560.88 min;
p,0.001; Figure 1B). This relation was also observed in the
subgroup of 40 patients with successful ROSC, i.e. the delay of
rtPA application was significantly shorter in patients who could be
discharged (10.261.1 min) compared to patients who died later
(16.061.7 min; p=0.01; Figure 1C). Both the success rate of CPR
with final ROSC and the cumulative survival to hospital discharge
were higher with shorter delay of thrombolysis administration
(Figure 2A+B).
Adverse Events
Adverse events were documented only in patients who
survived initial CPR (Table 2). Life threatening major
bleeding with the need for blood transfusion occurred in 9 of
40 patients (22.5%). 6 of these 9 patients could be discharged.
Intracranial hemorrhage was diagnosed in one patient (2.5%).
A good cerebral outcome with a CPC-score ,3 was present in
14 of the 19 patients (74%) who could be discharged
successfully.
Direct rtPA Related Costs
The cost for rtPA was approximately 1200 Euro per patient.
When effectiveness was measured by successful hospital
discharge, a number needed to treat (NNT) of 5.5 and a
treatment cost of 6000 Euro were calculated for rtPA per saved
life. When assessing good neurological outcome a NNT of 7.4
and a thrombolysis cost of approximately 8.900 Euro were
calculated.
Table 1. Baseline characteristics of the patients.
All (n=104) Resuscitation with thrombolysis P
Successful (n=40) Not successful (n=64)
Men (%) 43 (41) 20 (46.5) 23 (53.5) 0.22
Age 61.561.4 64.262.3 60.561.7 0.34
Hypertension (%) 60 (56) 24 (40) 36 (60) 0.84
CAD (%) 36 (34.6) 14 (38.9) 22 (61.1) 1.00
Congestive heart failure (%) 37 (35.6) 10 (27) 27 (73) 0.09
Diabetes mellitus (%) 31 (29.8) 14 (45.2) 17 (54.8) 0.39
PAD (%) 14 (13.5) 6 (42.9) 8 (57.1) 0.77
Stroke (%) 2 (2) 0 (0) 2 (100) 0.52
Previous PE (%) 15 (14.4) 8 (53.3) 7 (46.7) 0.25
Previous DVT (%) 13 (12.5) 7 (53.8) 6 (46.2) 0.24
PE verified 63 (60.6) 29 (46) 34 (54) 0.06
Wells score 7.860.21 8.060.30 7.760.29 0.45
CAD indicates coronary heart disease, PAD indicates peripheral arterial occlusive disease, DVT indicates deep venous thrombosis.
doi:10.1371/journal.pone.0008323.t001
Rescue-Thrombolysis in PE
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Figure 1. Time-outcome relation. Time of thrombolysis onset, CPR time after thrombolysis and total CPR duration in patients with and without
successful CPR (A), in patients with hospital discharge vs. those who died (B), and in patients with hospital discharge versus those with secondary
lethality after initially successful CPR.
doi:10.1371/journal.pone.0008323.g001
Rescue-Thrombolysis in PE
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Cardiac arrest in patients with PE is associated with a high
mortality [2,3]. Due to the persisting mechanical obstruction CPR
regularly fails in these patients. Surgical embolectomy may be a
meaningful approach in more stable patients but it is generally not
feasible under CPR conditions [14]. Fibrinolysis seems to be a
more logical alternative to resolve the obstruction. However,
current guidelines do not recommend thrombolysis therapy as first
line treatment option during CPR [9]. This is mainly based on the
difficult clinical diagnosis of PE in the emergency settings [9,15].
Given that reliable clinical diagnostic criteria are lacking [16,17], a
recent thrombolysis study in out-of-hospital resuscitation did not
show an overall benefit in a population of patients with presumed
low incidence of PE of 6% [11].
In the present investigation we minimized the risk of false
diagnosis, as PE was confirmed definitely in 63 patients. Moreover
in the remaining patients we used a combination of the Wells
score, d-dimer values and echocardiographic right ventricular
assessment to support the probability of PE.
Despite a diagnostic uncertainty in part of the patients our study
provides a rather clear and simple message: when thrombolysis is
considered during CPR, it should be given as early as possible. We
demonstrated a highly significant association between the delay of
rtPA administration and mortality.
The calculated low NNTs further suggest that the diagnosis of
PE was correct in most of the 41 patients, because a low
probability of PE would worsen the outcome and elevate the NNT
[11]. Moreover, this observed efficacy supports the notion that
early rtPA thrombolysis may be favorable in patients with cardiac
arrest and confirmed PE or high probability for PE.
Thus our results justify a prospective randomized investigation
with onset of thrombolysis therapy shortly after CPR initiation in
this patient population.
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